Sign In

Hanadie Yousef

CEO and Co-Founder at Juvena Therapeutics, Inc.

Dr. Hanadie Yousef is a prominent figure in the field of aging biology and tissue degeneration, boasting more than twenty years of experience in biomedical research. She founded Juvena Therapeutics in 2018, a biotech company focused on exploring the therapeutic potential of secreted proteins. With her expertise, Juvena has harnessed Artificial Intelligence to create a protein library aiding in the development of biologics to address degenerative diseases. One of their leading assets, JUV-161, targets muscle regeneration and metabolism, undergoing studies for treating Myotonic Dystrophy Type 1. Dr. Yousef has a history of high-impact research, supported by prestigious grants and fellowships, resulting in numerous patents.

Highlights

Jun 10 · EurekAlert
AI for longevity drug discovery: Breakthroughs and challenges: Free webinar on June 18 - EurekAlert
AI for longevity drug discovery: Breakthroughs and challenges: Free webinar on June 18 - EurekAlert
Aug 16 · Nature.com
Platelet factors attenuate inflammation and rescue cognition in ageing - Nature.com
Platelet factors attenuate inflammation and rescue cognition in ageing - Nature.com
Hanadie Yousef
Add to my network

Location

San Francisco Bay Area